SynthesisFrontiers in cellular and infection microbiology2022

Efficacy and safety of novel carbapenem-β-lactamase inhibitor combinations: Results from phase II and III trials.

Wei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.